IS7297A - Streptococcis Pneumoniae bóluefni - Google Patents

Streptococcis Pneumoniae bóluefni

Info

Publication number
IS7297A
IS7297A IS7297A IS7297A IS7297A IS 7297 A IS7297 A IS 7297A IS 7297 A IS7297 A IS 7297A IS 7297 A IS7297 A IS 7297A IS 7297 A IS7297 A IS 7297A
Authority
IS
Iceland
Prior art keywords
streptococcis
pneumoniae vaccine
pneumoniae
vaccine
streptococcis pneumoniae
Prior art date
Application number
IS7297A
Other languages
English (en)
Inventor
Anthony Joseph Laferriere Craig
Poolman Jan
Original Assignee
Glaxosmithkline Biologicals S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biologicals S.A. filed Critical Glaxosmithkline Biologicals S.A.
Publication of IS7297A publication Critical patent/IS7297A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS7297A 2001-12-18 2004-06-03 Streptococcis Pneumoniae bóluefni IS7297A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0130215.7A GB0130215D0 (en) 2001-12-18 2001-12-18 Vaccine
PCT/EP2002/014476 WO2003051392A2 (en) 2001-12-18 2002-12-18 Streptococcus pneumoniae vaccine

Publications (1)

Publication Number Publication Date
IS7297A true IS7297A (is) 2004-06-03

Family

ID=9927830

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7297A IS7297A (is) 2001-12-18 2004-06-03 Streptococcis Pneumoniae bóluefni

Country Status (19)

Country Link
US (1) US20050214329A1 (is)
EP (1) EP1463519A2 (is)
JP (1) JP2005516932A (is)
KR (1) KR20040074091A (is)
CN (1) CN1635904A (is)
AU (1) AU2002361007A1 (is)
BR (1) BR0215089A (is)
CA (1) CA2470645A1 (is)
CO (1) CO5590937A2 (is)
GB (1) GB0130215D0 (is)
HU (1) HUP0402471A3 (is)
IL (1) IL162383A0 (is)
IS (1) IS7297A (is)
MX (1) MXPA04006073A (is)
NO (1) NO20043018L (is)
PL (1) PL370804A1 (is)
RU (1) RU2004117775A (is)
WO (1) WO2003051392A2 (is)
ZA (1) ZA200404803B (is)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763244B1 (fr) 1997-05-14 2003-08-01 Pasteur Merieux Serums Vacc Composition vaccinale multivalente a porteur mixte
US7709001B2 (en) 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
US7955605B2 (en) 2005-04-08 2011-06-07 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
US20070184072A1 (en) 2005-04-08 2007-08-09 Wyeth Multivalent pneumococcal polysaccharide-protein conjugate composition
AU2011253684B8 (en) * 2005-04-08 2013-07-11 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
CN102716480B (zh) 2005-04-08 2023-03-21 惠氏有限责任公司 多价肺炎球菌多糖-蛋白质缀合物组合物
AU2012216698B2 (en) * 2005-12-22 2014-03-06 Glaxosmithkline Biologicals Sa Pneumococcal polysaccharide conjugate vaccine
CA2808919C (en) * 2005-12-22 2016-04-19 Glaxosmithkline Biologicals S.A. Streptococcus pneumoniae capsular saccharide vaccine
WO2007127668A2 (en) * 2006-04-26 2007-11-08 Wyeth Novel processes for coating container means which inhibit precipitation of polysaccharide-protein conjugate formulations
US8808707B1 (en) 2006-05-08 2014-08-19 Wyeth Llc Pneumococcal dosing regimen
WO2008022298A2 (en) * 2006-08-17 2008-02-21 The Uab Research Foundation Immunogenic pcpa polypeptides and uses thereof
CN1971275B (zh) * 2006-12-06 2012-07-04 云南沃森生物技术股份有限公司 肺炎链球菌6b型、18c型、19f型、23f型多糖结合物中游离多糖含量的测定方法
EP2142211A1 (en) * 2007-05-02 2010-01-13 GlaxoSmithKline Biologicals S.A. Vaccine
EP2687228B1 (en) 2007-06-26 2017-07-19 GlaxoSmithKline Biologicals S.A. Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
US20160228500A9 (en) * 2007-07-23 2016-08-11 Martina Ochs Immunogenic Polypeptides and Monoclonal Antibodies
AU2008280799B2 (en) * 2007-07-23 2013-07-11 Sanofi Pasteur Limited Immunogenic polypeptides and monoclonal antibodies
GB201003924D0 (en) * 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
WO2012075428A1 (en) 2010-12-03 2012-06-07 Sanofi Pasteur Limited Composition for immunization against streptococcus pneumoniae
DK2809349T3 (da) * 2012-01-30 2019-02-18 Serum Institute Of India Pvt Ltd Immunogen sammensætning
KR20150072444A (ko) * 2012-10-17 2015-06-29 글락소스미스클라인 바이오로지칼즈 에스.에이. 하나 이상의 스트렙토코커스 뉴모니애 캡슐 사카라이드 컨쥬게이트 및 해모필루스 인플루엔자로부터의 단백질 Ｅ 및／또는 ＰｉｌＡ를 포함하는 단백질 성분을 포함하는 면역원성 조성물
US20140105927A1 (en) * 2012-10-17 2014-04-17 Glaxosmithkline Biologicals S.A. Immunogenic composition
US9815886B2 (en) 2014-10-28 2017-11-14 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
CN106109486A (zh) * 2015-07-06 2016-11-16 北京科兴中维生物技术有限公司 一种组合物及其制备方法与应用
US11246918B2 (en) 2017-02-03 2022-02-15 Eva Barbara Schadeck Haemophilus influenzae saccharide-carrier conjugate compositions and uses thereof
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
US10729763B2 (en) 2017-06-10 2020-08-04 Inventprise, Llc Mixtures of polysaccharide-protein pegylated compounds
BR112019026192B1 (pt) * 2017-06-10 2022-05-10 Inventprise, Llc Vacinas de conjugado multivalente com polissacarídeos de conjugado bivalente ou multivalente que fornecem imunogenicidade e avidez melhoradas
AU2019215216A1 (en) 2018-02-05 2020-07-23 Sk Bioscience Co., Ltd. Multivalent pneumococcal polysaccharide-protein conjugate composition
BR112020021296A2 (pt) * 2018-04-18 2021-01-26 Sk Bioscience Co., Ltd. polissacarídeo capsular de streptococcus pneumoniae e conjugado imunogênico do mesmo

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811102A (en) * 1995-06-07 1998-09-22 National Research Council Of Canada Modified meningococcal polysaccharide conjugate vaccines
FR2763244B1 (fr) * 1997-05-14 2003-08-01 Pasteur Merieux Serums Vacc Composition vaccinale multivalente a porteur mixte
CZ303653B6 (cs) * 1999-03-19 2013-01-30 Smithkline Beecham Biologicals S. A. Imunogenní prostredek

Also Published As

Publication number Publication date
CA2470645A1 (en) 2003-06-26
IL162383A0 (en) 2005-11-20
EP1463519A2 (en) 2004-10-06
CN1635904A (zh) 2005-07-06
NO20043018L (no) 2004-07-15
HUP0402471A3 (en) 2005-04-28
CO5590937A2 (es) 2005-12-30
PL370804A1 (en) 2005-05-30
KR20040074091A (ko) 2004-08-21
GB0130215D0 (en) 2002-02-06
WO2003051392A3 (en) 2003-11-13
JP2005516932A (ja) 2005-06-09
MXPA04006073A (es) 2005-03-31
WO2003051392A2 (en) 2003-06-26
BR0215089A (pt) 2004-11-16
RU2004117775A (ru) 2005-04-20
AU2002361007A1 (en) 2003-06-30
HUP0402471A2 (hu) 2005-03-29
ZA200404803B (en) 2005-08-29
US20050214329A1 (en) 2005-09-29

Similar Documents

Publication Publication Date Title
IS7297A (is) Streptococcis Pneumoniae bóluefni
DK1390066T3 (da) Vaccinesammensætning
NO20031483L (no) Vaksine
DK1427444T3 (da) West-nil-vaccine
NO20024172D0 (no) Vaksine
DE50206021D1 (de) Schlauchklemme
DE50103741D1 (de) Welle-Nabe-Verbindung
NO20033882D0 (no) Vaksine
ATE335486T1 (de) Hydrazono-malonitrile
DE1319930T1 (de) Coriolismassendurchflussmesser
DE50203412D1 (de) Schwenkkolbenverdränger
ATE355059T1 (de) Isoxazolopyridinone
DE50203093D1 (de) Losradlager
ATE319694T1 (de) Phenylalkyne
ATA18372001A (de) Gelenksbolzenbaueinheit
DE50202088D1 (de) Garmodulsystem
DE60229395D1 (de) Altung
ATA17102002A (de) Distanzhalter
DE10295006D2 (de) Bauwerksabdichtung
DE50108381D1 (de) Synchronisierschaltungsanordnung
ATA13992002A (de) Schlackengranulierungsanlage
ATE345337T1 (de) Delta1 -pyrroline
AT500276B1 (de) Radschwenksystem
ATA7462001A (de) Radspannwerk
DE10295832D2 (de) Dioxathianone